The report will start with Professor Keasling's growth experience, focusing on how his lab utilizes microbial cell factories, metabolic engineering, and synthetic biology to produce complex natural products and intricate molecules that are beyond the reach of chemical synthesis.Plants produce some of the most potent human therapeutics and have been used for millennia to treat illnesses. Two examples are vinblastine, the chemotherapeutic, and QS-21, an adjuvant used in several vaccines. Both molecules are large, highly decorated terpenes. Vinblastine is extracted from Catharanthus roseus and requires 1 ton of dried leaves to obtain 1 g. In a similar vein, QS-21 is extracted from the tree bark of Quillaja saponaria, and its isolation is complicated as the plant extract contains a multitude of different structurally related Quillaja saponins, rendering the purification process highly laborious and low yielding. To alleviate supply issues, we have engineered Saccharomyces cerevisiae to produce these molecules.
嘉宾介绍
Jay D Keasling
美国国家工程院院士